You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

List of Excipients in API amlodipine besylate and olmesartran medoxomil

✉ Email this page to a colleague

« Back to Dashboard

Excipients in ANDA-approved (generic) drugs containing amlodipine besylate and olmesartran medoxomil

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC	Excipient
Alembic Pharmaceuticals Limited	amlodipine besylate and olmesartran medoxomil	46708-212	CELLULOSE, MICROCRYSTALLINE
Alembic Pharmaceuticals Limited	amlodipine besylate and olmesartran medoxomil	46708-212	CROSCARMELLOSE SODIUM
Alembic Pharmaceuticals Limited	amlodipine besylate and olmesartran medoxomil	46708-212	MAGNESIUM STEARATE
>Company	>Ingredient	>NDC	>Excipient

Detailed excipient profiles for amlodipine besylate and olmesartran medoxomil

Excipient focus: CELLULOSE, MICROCRYSTALLINE

amlodipine besylate and olmesartran medoxomil drug variants containing CELLULOSE, MICROCRYSTALLINE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Alembic Pharmaceuticals Limited	amlodipine besylate and olmesartran medoxomil	46708-212
Alembic Pharmaceuticals Inc	amlodipine besylate and olmesartran medoxomil	62332-212
>Company	>Ingredient	>NDC

amlodipine besylate and olmesartran medoxomil drug variants not containing CELLULOSE, MICROCRYSTALLINE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: CROSCARMELLOSE SODIUM

amlodipine besylate and olmesartran medoxomil drug variants containing CROSCARMELLOSE SODIUM

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Alembic Pharmaceuticals Limited	amlodipine besylate and olmesartran medoxomil	46708-212
Alembic Pharmaceuticals Inc	amlodipine besylate and olmesartran medoxomil	62332-212
>Company	>Ingredient	>NDC

amlodipine besylate and olmesartran medoxomil drug variants not containing CROSCARMELLOSE SODIUM

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: MAGNESIUM STEARATE

amlodipine besylate and olmesartran medoxomil drug variants containing MAGNESIUM STEARATE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Alembic Pharmaceuticals Limited	amlodipine besylate and olmesartran medoxomil	46708-212
Alembic Pharmaceuticals Inc	amlodipine besylate and olmesartran medoxomil	62332-212
>Company	>Ingredient	>NDC

amlodipine besylate and olmesartran medoxomil drug variants not containing MAGNESIUM STEARATE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: POLYETHYLENE GLYCOL 3350

amlodipine besylate and olmesartran medoxomil drug variants containing POLYETHYLENE GLYCOL 3350

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Alembic Pharmaceuticals Limited	amlodipine besylate and olmesartran medoxomil	46708-212
Alembic Pharmaceuticals Inc	amlodipine besylate and olmesartran medoxomil	62332-212
>Company	>Ingredient	>NDC

amlodipine besylate and olmesartran medoxomil drug variants not containing POLYETHYLENE GLYCOL 3350

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SILICON DIOXIDE

amlodipine besylate and olmesartran medoxomil drug variants containing SILICON DIOXIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Alembic Pharmaceuticals Limited	amlodipine besylate and olmesartran medoxomil	46708-212
Alembic Pharmaceuticals Inc	amlodipine besylate and olmesartran medoxomil	62332-212
>Company	>Ingredient	>NDC

amlodipine besylate and olmesartran medoxomil drug variants not containing SILICON DIOXIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: STARCH, POTATO

amlodipine besylate and olmesartran medoxomil drug variants containing STARCH, POTATO

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Alembic Pharmaceuticals Limited	amlodipine besylate and olmesartran medoxomil	46708-212
Alembic Pharmaceuticals Inc	amlodipine besylate and olmesartran medoxomil	62332-212
>Company	>Ingredient	>NDC

amlodipine besylate and olmesartran medoxomil drug variants not containing STARCH, POTATO

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: TALC

amlodipine besylate and olmesartran medoxomil drug variants containing TALC

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Alembic Pharmaceuticals Limited	amlodipine besylate and olmesartran medoxomil	46708-212
Alembic Pharmaceuticals Inc	amlodipine besylate and olmesartran medoxomil	62332-212
>Company	>Ingredient	>NDC

amlodipine besylate and olmesartran medoxomil drug variants not containing TALC

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: TITANIUM DIOXIDE

amlodipine besylate and olmesartran medoxomil drug variants containing TITANIUM DIOXIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Alembic Pharmaceuticals Limited	amlodipine besylate and olmesartran medoxomil	46708-212
Alembic Pharmaceuticals Inc	amlodipine besylate and olmesartran medoxomil	62332-212
>Company	>Ingredient	>NDC

amlodipine besylate and olmesartran medoxomil drug variants not containing TITANIUM DIOXIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.